Management of sepsis [17]

New England Journal of Medicine

Volumn 356, Issue 11, 2007, Pages 1179-1181

  Van Cromphaut, Sophie ^a   Wilmer, Alexander ^a   Van Den Berghe, Greet ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; ANTIDIABETIC AGENT;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; GLUCOSE BLOOD LEVEL; HOSPITALIZATION; HUMAN; HYPOGLYCEMIA; INCIDENCE; INSULIN TREATMENT; INTENSIVE CARE UNIT; LETTER; MORTALITY; OUTCOME ASSESSMENT; POLYNEUROPATHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPSIS; TREATMENT DURATION; TREATMENT OUTCOME; FEMALE; LENGTH OF STAY; MALE; MIDDLE AGED; NOTE;

FEMALE; HOSPITAL MORTALITY; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; SEPSIS;

EID: 33947238725     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001;345:1359-67.
2. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006;354:449-61.
3. Van den Berghe G, Wilmer A, Milants I, et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes 2006;55:3151-9.
4. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992;101:1644-55.